Skip to main content
Retour
Watch Compare

Moleculin Biotech, Inc.

Qualité des données : 100%
MBRX
Nasdaq Manufacturing Chemicals
2,54 €
▲ 0,11 € (4,53%)
Cap. Boursière: 13,55 M
Prix
2,54 €
Cap. Boursière
13,55 M
Fourchette du Jour
2,42 € — 2,58 €
Fourchette 52 Semaines
1,79 € — 28,60 €
Volume
103 513
Ouverture 2,44 €
Moyenne 50J / 200J
3,00 €
15,43% below
Moyenne 50J / 200J
8,68 €
70,74% below

Quick Summary

Points Clés

Negative free cash flow of -22,74 M

Croissance

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Qualité

Return on Equity
N/A
ROIC-139,90%
Net MarginN/A
Op. MarginN/A

Sécurité

Debt / Equity
N/A
Current Ratio1,39
Interest CoverageN/A

Valorisation

PE (TTM)
-0,40
Au-dessus de la moyenne du secteur (-1,48)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A

Historique des Prix

Tendances Financières

Comparaison Sectorielle

vs médiane du secteur Manufacturing (1364 pairs)
Métrique Action Médiane du Secteur
P/E -0,4 -1,5
P/B — 1,6
ROE % — -53,4
Net Margin % — -41,5
Rev Growth 5Y % — 1,8
D/E — 0,3

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 0,0 Net Income (TTM) -33,56 M
ROE N/A ROA -160,02%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -22,74 M
ROIC -139,90% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 1,39
Interest Coverage N/A Asset Turnover 0,00
Working Capital 2,20 M Tangible Book Value -26,92 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -0,40 Forward P/E N/A
P/B Ratio N/A P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -167,73%
Market Cap 13,55 M Enterprise Value 6,85 M
Per Share
EPS (Diluted TTM) N/A Revenue / Share 0,00
FCF / Share -4,26 OCF / Share -4,26
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 67,74%
SBC-Adj. FCF -24,29 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 0,0 0,0 0,0 0,0 0,0
Net Income -33,56 M -21,76 M -29,77 M -29,03 M -15,89 M
EPS (Diluted) — — — — —
Gross Profit — — — — —
Operating Income -25,10 M -26,64 M -29,63 M -30,64 M -22,97 M
EBITDA — — — — —
R&D Expenses 15,89 M 17,73 M 19,49 M 18,97 M 14,42 M
SG&A Expenses — — — — —
D&A 90 000,0 126 000,0 127 000,0 130 000,0 164 000,0
Interest Expense — — — 240 000,0 306 000,0
Income Tax 0,0 0,0 0,0 0,0 0,0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 22,13 M 16,93 M 38,22 M 57,42 M 84,09 M
Total Liabilities 7,12 M 10,95 M 12,14 M 5,23 M 5,10 M
Shareholders' Equity 15,01 M 5,98 M 26,07 M 52,19 M 78,99 M
Total Debt — — — — —
Cash & Equivalents 8,88 M 4,28 M 23,55 M 43,15 M 70,90 M
Current Assets 9,69 M 5,19 M 26,27 M 45,60 M 72,50 M
Current Liabilities 6,85 M 5,36 M 6,82 M 4,82 M 3,62 M